Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

ISPE Names Dr. Thomas Zimmer as Vice President of European Operations

Published: Wednesday, November 13, 2013
Last Updated: Wednesday, November 13, 2013
Bookmark and Share
Dr. Zimmer will be responsible for leading ISPE’s business development and advancing strategic relationships in Europe.

Dr. Zimmer began his work by engaging with global Members at ISPE’s Annual Meeting in Washington, DC. When he returns to Europe, Dr. Zimmer will work closely with ISPE’s volunteer and staff advisory teams, industry representatives, regulatory organizations and Member groups to strengthen ISPE’s relationships and deliver increasing value to ISPE’s European stakeholders. Dr. Zimmer will also serve as the primary European liaison to ISPE’s headquarters in Tampa, Fla. USA.

“Thomas joins ISPE with a strong foundation of pharmaceutical industry knowledge and relationships both within the Society and in the European professional community at large,” said ISPE President and CEO Nancy S. Berg. “Thomas’s first-hand knowledge of the European regulatory environment and industry processes will be an important asset to ISPE as it continues to build best-in-class knowledge transfer offerings that are tailored to the needs of the pharmaceutical and biopharmaceutical industries both in Europe and around the world.”

Dr. Zimmer joins ISPE with more than 30 years of experience in the pharmaceutical industry. He is a licensed pharmacist and Qualified Person. Prior to joining ISPE, Dr. Zimmer was Senior Vice President at Boehringer Ingelheim. During his 32 years with the company, he gained experience in development, production, quality and supply chain operations. Prior to becoming Senior Vice President, Dr. Zimmer served as Plant Manager in France, and he was International Project Leader for the Production Alliance Europe. He worked in various cultural environments in North America, South America and several countries in Europe. He holds a PhD in Pharmaceutical Technology from the University of Frankfurt am Main.

In addition to his professional experience, Dr. Zimmer has held numerous advisory posts within the pharmaceutical industry. He is a current member of the ISPE European Forum, a contributor to the ISPE Regulatory and Compliance Committee and a current member and former chair of the ISPE International Leadership Forum. Additionally, he is the former chair of the industrial advisory board of the University of Applied Sciences at the Beuth Institute in Berlin, former chair of the EFPIA Anti-counterfeiting working group, a former member of the WHO IMPACT taskforce, group regulatory enforcement, former chair of the board of directors for the PSI (Pharmaceutical Security Institute) and a former member in the EFPIA manufacturing GMP working group, product lifecycle team, technical development and operations committee TDOC. Dr. Zimmer has been an ISPE Member since 2005.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

ISPE Announces Development of New Drug Shortages Prevention Plan
Drug Shortages Prevention Plan for the pharmaceutical and biopharmaceutical industry.
Tuesday, April 29, 2014
ISPE Issues Global Drug Shortage Survey
Preliminary results are expected in June 2013.
Tuesday, February 26, 2013
Risk-based Control Strategies in Pharmaceutical Industries at ISPE Brussels Conference
The conference will be the global launch of the Baseline® Guide: Risk-Based Manufacture of Pharmaceutical Products.
Friday, July 23, 2010
Scientific News
Breaking Cell Barriers with Retractable Protein Nanoneedles
Adapting a bacterial structure, institute researchers have developed protein actuators that can mechanically puncture cells.
Retractable Protein Nanoneedles
The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.
Leukemia’s Surroundings Key to its Growth
Researchers at The University of Texas at Austin have discovered that a type of cancer found primarily in children can grow only when signaled to do so by other nearby cells that are noncancerous.
Common Cell Transformed into Master Heart Cell
By genetically reprogramming the most common type of cell in mammalian connective tissue, researchers at the University of Wisconsin—Madison have generated master heart cells — primitive progenitors that form the developing heart.
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Genetic Mutation that Prevents Diabetes Complications
The most significant complications of diabetes include diabetic retinal disease, or retinopathy, and diabetic kidney disease, or nephropathy. Both involve damaged capillaries.
A Crystal Clear View of Biomolecules
Fundamental discovery triggers paradigm shift in crystallography.
Could the Food we Eat Affect Our Genes?
Almost all of our genes may be influenced by the food we eat, according to new research.
NIH Seeks Research Applications to Study Zika in Pregnancy, Developing Fetus
Institute has announced that the new effort seeks to understand virus effect on reproduction and child development.
Iron in the Blood Could Cause Cell Damage
Concentrations of iron similar to those delivered through standard treatments can trigger DNA damage within 10 minutes, when given to cells in the laboratory.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!